Login / Signup

Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer's disease-like pathology.

David Baglietto-VargasStefania FornerLena CaiAlessandra Cadete MartiniLaura Trujillo-EstradaVivek SwarupMarie Minh Thu NguyenKelly Do HuynhDominic I JavonilloKristine Minh TranJimmy PhanShan JiangEnikö A KramárCristina Nuñez-DiazGabriela Balderrama-GutierrezFranklin GarciaJessica ChildsCarlos J Rodriguez-OrtizJuan Antonio Garcia-LeonMasashi KitazawaMohammad ShahnawazDina P MatheosXinyi MaCelia Da CunhaKen C WallsRahasson R AgerClaudio SotoAntonia GutierrezInes Moreno-GonzalezAli MortazaviAndrea J TennerGrant R MacGregorMarcelo WoodKim N GreenFrank M LaFerla
Published in: Nature communications (2021)
The majority of Alzheimer's disease (AD) cases are late-onset and occur sporadically, however most mouse models of the disease harbor pathogenic mutations, rendering them better representations of familial autosomal-dominant forms of the disease. Here, we generated knock-in mice that express wildtype human Aβ under control of the mouse App locus. Remarkably, changing 3 amino acids in the mouse Aβ sequence to its wild-type human counterpart leads to age-dependent impairments in cognition and synaptic plasticity, brain volumetric changes, inflammatory alterations, the appearance of Periodic Acid-Schiff (PAS) granules and changes in gene expression. In addition, when exon 14 encoding the Aβ sequence was flanked by loxP sites we show that Cre-mediated excision of exon 14 ablates hAβ expression, rescues cognition and reduces the formation of PAS granules.
Keyphrases